Clinical Trials & Protocols

• Canary Prostate Active Surveillance Study (PASS) Is Open For Registration (November 2008)

• ABIRATERONE:  A Hormone Therapy for "Hormone Refractory" Prostate Cancer - An Introduction (September 2008)

• Forthcoming Protocol Combining Active Surveillance And Biomarker Analysis (June 2008)

• Chemotherapy - Updated Survival Data from TAX 327 Study: Docetaxel Plus Prednisone Versus Mitoxanthrone Plus Prednisone for Advanced Prostate Cancer. (JCO January 10, 2008) (March 2008)

• Final Results Of Dendreon Vaccine Trial (July 2005)

• Interim Results Of High-Dose Calcitriol/Docetaxel (C/D) versus Docetaxel (D) In Men With HRPC (July 2005)

• Phase III Trial Of Toremifene In High-Grade Prostatic Intraepithelial Now Open For Registration (April 2005)

• Chemotherapy News From The June 2004 Asco Meeting:  Results Of Two  Important Chemotherapy Trials In Men With Metastatic Hormone  Refractory Prostate Cancer (July 2004)

• Dendreon Launches A New Vaccine Protocol For Men With Metastateic Hormone Refractory PCa With Gleason Sums < 7 (September 2003)
• An Online NCI Tool For Finding Clinical Trials For Patients - (August 2003)
• Protocol Study of Atrasentan (November 2002)

« Back to topic index